Prevalence of Primary Hypothyroidism in Patients with Non-Alcoholic Fatty Liver Disease

International Journal of Medical Science
© 2023 by SSRG - IJMS Journal
Volume 10 Issue 5
Year of Publication : 2023
Authors : Dina Aljundi, Ruba Salman, Daad Daghman
pdf
How to Cite?

Dina Aljundi, Ruba Salman, Daad Daghman, "Prevalence of Primary Hypothyroidism in Patients with Non-Alcoholic Fatty Liver Disease," SSRG International Journal of Medical Science, vol. 10,  no. 5, pp. 12-18, 2023. Crossref, https://doi.org/10.14445/23939117/IJMS-V10I5P103

Abstract:

Introduction: There is a possible relationship between NAFLD and hypothyroidism. One suggested mechanism to explain this relationship is the well-known association between hypothyroidism and various metabolic syndrome components often present in the context of NAFLD. Objective: This study aims to estimate the prevalence of hypothyroidism in patients with non-alcoholic fatty liver disease. Methods: A case-control study of 128 patients diagnosed with NAFLD by ultrasonographic findings without a history of thyroid disorders participated in this study, who attended Tishreen University Hospital in Lattakia, Syria, during the period from May 2022 to July 2023, 128 age and gendermatched control subjects with normal liver on ultrasound, to compare the prevalence of primary hypothyroidism between the two groups. Results: Primary hypothyroidism was more prevalent among NAFLD patients by 19.5% compared to 8.5% in the controls, with a statistically significant difference (P-value: 0.001). The mean TSH value was higher in the NAFLD group compared to the controls (3.9 mui/l compared to 2.4 mui/l in the controls) with a statistically significant difference (P-value: 0.04); as for the average value of FT4, it was lower in the NAFLD group compared to the controls (1.10 ng/dl compared to 1.22 in the controls) with a significant statistical difference (P-value: 0.01). Conclusions: A higher prevalence of primary hypothyroidism was demonstrated in the NAFLD group, with both clinical and subclinical types, and this may indicate a relationship between hypothyroidism and NAFLD.

Keywords:

Insulin resistance, Metabolic syndrome, Non-alcoholic fatty liver disease, Primary hypothyroidism, Steatosis.

References:

[1] Mikako Obika, and Hirofumi Noguchi, “Diagnosis and Evaluation of Non-alcoholic Fatty Liver Disease,” Experimental Diabetes Research, pp. 1-12, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[2] J.K. Dowman, J.W. Tomlinson, and P.N. Newsome, “Pathogenesis of Non-Alcoholic Fatty Liver Disease.” QJM: An International Journal of Medicine, vol. 103, no. 2, pp. 71-83, 2009.
[CrossRef] [Google Scholar] [Publisher Link]
[3] Vignan Manne, Priya Handa, and Kris V. Kowdley, “Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis,” Clinics in Liver Disease, vol. 22, no. 1, pp. 23-37, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[4] Kenneth Cusi et al., “American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Non-alcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD),” Endocrine Practice, vol. 28, no. 5, pp. 528-562, 2022.
[CrossRef] [Google Scholar] [Publisher Link]
[5] Chalasani Naga et al., “The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association,” American Journal of Gastroenterology, vol. 107, no. 6, pp. 811-826, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[6] E. Rinella Mary et al., “AASLD Practice Guidance on the Clinical Assessment and Management of Non-alcoholic Fatty Liver Disease,” Hepatology, vol. 77, no. 5, pp. 1797-1835, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[7] Amedeo Lonardo et al., “Pathogenesis of Hypothyroidism-induced NAFLD: Evidence for a Distinct Disease Entity?,” Digestive and Liver Disease, vol. 51, no. 4, pp. 462-470, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[8] Tomislav Kizivat et al., “Hypothyroidism and Non-alcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications,” Journal of Clinical and Translational Hepatology, vol. 8, no. 3, pp. 1-7, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[9] A.L. Sberna et al., “EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-alcoholic Fatty Liver Disease,” Journal of Hepatology, vol. 64, no. 6, pp. 1388-1402, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[10] M. Ammar Kalas et al., “Abnormal Liver Enzymes: A Review for Clinicians,” World Journal of Hepatology, vol. 13, no. 11, pp. 1688-1698, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[11] Seung Soo Lee, and Seong Ho Park, “Radiologic Evaluation of Non-alcoholic Fatty Liver Disease,” World Journal of Gastroenterology, vol. 20, no. 23, pp. 7392-7402, 2014.
[CrossRef] [Google Scholar] [Publisher Link]
[12] Simon H.S. Pearce et al., “2013 ETA Guideline: Management of Subclinical Hypothyroidism,” European Thyroid Journal, vol. 2, no. 4, pp. 215-228, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[13] Jessica K. Dyson, Quentin M. Anstee, and Stuart McPherson, “Non-Alcoholic Fatty Liver Disease: A Practical Approach to Diagnosis and Staging,” Frontline Gastroenterology, vol. 5, no. 3, pp. 211-218, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[14] Gurnoor Kaur Dhaliwal, Satya Bhushan Nayyar, and Manish Chandey, “To Study the Prevalence of Hypothyroidism in Non-Alcoholic Fatty Liver Disease in Northern Population,” Journal of Evidence-Based Medicine and Healthcare, vol. 8, no. 33, pp. 3073-3077, 2021.
[Publisher Link]
[15] Mangesh R. Pagadala et al., “Prevalence of Hypothyroidism in Non-alcoholic Fatty Liver Disease,” Digestive Diseases and Sciences, vol. 57, no. 2, pp. 528-534, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Pathik Parikh, Aniruddha Phadke, and Prabha Sawant, “Prevalence of Hypothyroidism in Non-alcoholic Fatty Liver Disease in Patients Attending a Tertiary Hospital in Western India,” Indian Journal of Gastroenterology, vol. 34, no. 2, pp. 169-173, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[17] Ulla Ludwig et al., “Subclinical and Clinical Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of a Random Population Sample Aged 18 to 65 Years,” BMC Endocrine Disorders, vol. 15, no. 41, pp. 1-7, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[18] Huixing Liu, and Daoquan Peng, “Update on Dyslipidemia in Hypothyroidism: The Mechanism of Dyslipidemia in Hypothyroidism,” Endocrine Connections, vol. 11, no. 2, pp. 1-15, 2022.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Ghada Rafik Hasan, and Hiam Kamel Fadel, “The Effect of the Water Extract of Soybean Seeds in Two Different Doses on Hyperthyroidism,” SSRG International Journal of Agriculture and Environmental Science, vol. 7, no. 1, pp. 56-61, 2020.
[CrossRef] [Publisher Link]
[20] Weiwei He et al., “Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis,” Frontiers in Endocrinology, vol. 8. pp. 1-11, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[21] Simonetta Lugari et al., “Hypothyroidism and Nonalcoholic Fatty Liver Disease - A Chance Association?,” Hormone Molecular Biology and Clinical Investigation, vol. 41, no. 1, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[22] Sudha Ambiger, and Shrikanth P. Chincholika, “Study of Liver Function Tests in Patients of Hypothyroidism,” International Journal of Contemporary Medical Research, vol. 6, no. 8, pp. 1-4, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[23] K.C.B. Tan, S.W.M. Shiu, and A.W.C. Kung, “Effect of Thyroid Dysfunction on High-Density Lipoprotein Subfraction Metabolism: Roles of Hepatic Lipase and Cholesteryl Ester Transfer Protein,” The Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 8, pp. 2921-2924, 1998.
[CrossRef] [Google Scholar] [Publisher Link]